Newsroom

Sorted by: Latest

-

Samson Rock Capital LLP UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: SAMSON ROCK CAPITAL LLP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named....
-

SPAR Canada et ReposiTrak lancent « Touchless Retail™ » sur le marché canadien afin de proposer des solutions de mise en rayon professionnelles à un coût deux fois moins élevé que les solutions traditionnelles

TORONTO & SALT LAKE CITY--(BUSINESS WIRE)--SPAR Canada, la filiale canadienne du groupe SPAR (OTCQB : SGRP), et ReposiTrak (NYSE : TRAK) ont annoncé aujourd’hui le lancement au Canada de Touchless Retail™, un programme de merchandising en magasin qui permet aux marques canadiennes d’accéder à des services spécialisés à un tarif forfaitaire représentant généralement environ la moitié du coût habituel. Lancé aux États-Unis en début d’année, Touchless Retail s’étend désormais au Canada, ce qui va...
-

Glaukos Announces Positive Topline Results from Phase 4 Prospective Randomized Controlled Clinical Trial Evaluating iDose® TR in Combination with Cataract Surgery

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced positive topline results from the Phase 4 prospective, randomized, controlled clinical trial (GLK-101-04) evaluating iDose® TR administered in conjunction with cataract surgery compared to cataract surgery alone in patients with open-angle glaucoma (OA...
-

Pebblebrook Hotel Trust Completes $10.0 Million Sale of The Hotel Zags

BETHESDA, Md.--(BUSINESS WIRE)--Pebblebrook Hotel Trust Completes $10.0 Million Sale of The Hotel Zags...
-

Seaport Therapeutics Presents Additional Pharmacokinetic Data from Phase 1 Clinical Trial of GlyphAgo™ at the 39th European College of Neuropsychopharmacology (ECNP) Congress

BOSTON--(BUSINESS WIRE)--Seaport Therapeutics, Inc. (Nasdaq: SPTX) (“Seaport” or the “Company”), a clinical-stage therapeutics company developing novel neuropsychiatric medicines, today announced the presentation of Phase 1 clinical data for GlyphAgo™ (SPT-320 or Glyph Agomelatine) at the 39th European College of Neuropsychopharmacology (ECNP) Congress, taking place October 10-13, 2026, in Munich, Germany. The poster represents the first scientific presentation of data from the GlyphAgo Phase 1...
-

Fingerprint Ranked #1 Best Fraud Detection Software on G2, Driven by Customer Reviews

CHICAGO--(BUSINESS WIRE)--Fingerprint, the industry leader in device intelligence, today announced it ranked #1 in G2’s Best Fraud Detection Software category. G2, the world’s largest software marketplace review platform, bases its rankings on feedback from real users. Fingerprint earned the #1 fraud detection software ranking based on customer reviews that highlighted detection accuracy, seamless integration, rapid deployment, and ease of use. Thousands of businesses rely on Fingerprint every...
-

Avolon Orders 250 Airbus and Boeing Aircraft

DUBLIN--(BUSINESS WIRE)--Avolon, a leading global aviation finance company, today announced firm orders for 250 new-technology aircraft from Boeing and Airbus and issued an update for the third quarter (‘Q3’) 2026. Orders for 250 New-Technology Aircraft Entered into a firm order with Boeing for 140 737 MAX aircraft Entered into a firm order with Airbus for 110 aircraft, comprising 75 A320neo family aircraft and 35 A330neo family aircraft, with options for a further 100 aircraft The new orders s...
-

Consonance Capital Partners Closes Oversubscribed Third Fund at $1.35 Billion

NEW YORK--(BUSINESS WIRE)--Consonance Capital Partners (“Consonance”), a leading U.S.-based healthcare private equity firm, today announced the closing of Consonance Private Equity III, L.P. (“Fund III”), with commitments totaling $1.35 billion. After just under four months in the market, Consonance held its final close on Fund III at its hard cap in a heavily oversubscribed process. Consistent with its predecessor funds, Fund III will focus on investments in U.S. healthcare companies in the lo...
-

Seiden Law LLP發布聲明:Yim Leak家屬向聯合國人權專家提出緊急申訴,指稱未經法院審理即被公開認定有罪,促請泰國履行條約承諾

華盛頓特區--(BUSINESS WIRE)--(美國商業資訊)-- Seiden Law LLP是柬埔寨商人Yim Leak的首席全球法律顧問。該律所今日表示,Yim先生及其妻子的國際法律顧問Jared Genser已請求兩位聯合國特別報告員向泰國政府發出緊急申訴。該請求代表這對夫婦及其七歲兒子提出,指稱泰國在法院審理前公開認定該家庭有罪,並在未舉行聽證的情況下凍結其資產(包括其未成年兒子的儲蓄),不符合其國際人權承諾。 九個月內六次官方聲明,未有任何法院提出指控。 據該聲明,2025年12月至2026年9月期間,泰國官員六次將Yim先生描述為犯罪網路的核心:包括兩次由泰國政府首腦主持的新聞發布會、一次在眾議院的發言,以及三份政府新聞稿。泰國政府首腦表示該網路“已被認定犯有”相關罪行。當被問及嫌疑人的律師時,他表示:“無論律師多麼高明,如果你像這樣明顯違法並給人民帶來麻煩,你就不可能戰勝你自己當事人所犯下的罪行。” 關於這些指控,任何法院均未對Yim先生或其妻子提出指控。沒有任何法院審理過他們中的任何一人。 未經聽證即凍結,證據檢驗要到2027年。 據該聲明,本案被凍結資產——政府目...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Emerging Markets AlphaDEX UCITS ETF 08.10.2026 FEM IE00B8X9NX34  300,002.00 USD  15,597,881.16   51.993  ...